A/RES/74/178
International cooperation to address
and counter the world drug problem
well-being among individuals, families and communities and reducing the adverse
consequences of drug abuse for individuals and society as a whole;
59. Also recognizes the continued efforts to promote coordination and
cooperation on drug-related matters within the United Nations system;
60. Calls upon the United Nations Office on Drugs and Crime, the
Commission on Narcotic Drugs, the International Narcotics Control Board , the World
Health Organization and other United Nations entities with pertinent technical and
operational expertise, within their mandates, to continue to provide, upon request,
advice and assistance to States that are reviewing and updating their drug po licies, in
compliance with the three international drug control conventions, taking into account
their national priorities and needs through, among other things, the promotion of the
exchange of information and best practices on scientific evidence -based policies
adopted by States;
61. Calls upon Member States to promote and strengthen the exchange of
information and, as appropriate, drug-related criminal intelligence among law
enforcement and border control agencies, including through the United Nations
Office on Drugs and Crime multilateral portals and regional information centres and
networks, and to promote joint investigations and coordinate operations, in
conformity with national legislation, and training programmes at all levels, in order
to identify, disrupt and dismantle organized criminal groups operating transnationally
that are involved in any activities related to the illicit production of and trafficking in
narcotic drugs and psychotropic substances and the diversion of their precursors and
related money-laundering;
62. Reiterates the commitment of Member States to share relevant information
with, as appropriate, and strengthen the capacity of the World Health Organization,
the United Nations Office on Drugs and Crime, the International Narcoti cs Control
Board and other relevant international and regional organizations to prioritize the
review of the most prevalent, persistent and harmful new psychoactive substances
and to facilitate informed scheduling decisions by the Commission on Narcotic
Drugs;
63. Encourages Member States to fully support the efforts of the World Health
Organization to review substances, within its mandate under the three international
drug control conventions, particularly through its Expert Committee on Drug
Dependence;
64. Also encourages Member States to enhance the capacity of law
enforcement agencies to detect and identify new psychoactive substances and
amphetamine-type stimulants, including methamphetamine, and promote cross border cooperation and information-sharing to prevent their abuse and diversion,
including through the use of existing International Narcotics Control Board and
United Nations Office on Drugs and Crime tools and projects;
65. Further encourages Member States to establish and strengthen
partnerships and information exchange with industries, in particular with chemical
and pharmaceutical industries and other relevant private sector entities, and
encourage the use of the Guidelines for a Voluntary Code of Practice for the Chemical
Industry, issued by the International Narcotics Control Board, and the Board ’s model
memorandum of understanding between Governments and private sector partners, as
and where appropriate, bearing in mind the important role that these industries can
play in addressing and countering the world drug problem;
66. Calls upon Member States to commit themselves to implementing timely,
scientific evidence-based control or regulatory measures within national legislative
and administrative systems to tackle and manage the challenge of new psychoactive
14/23
19-22335
Select target paragraph3
Connect to a paragraph
Connect to an entity
Disable highlights
Add to table of contents